- VolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annual Meeting
- VolitionRx Limited to Present at Jefferies Global Healthcare Conference
- VolitionRx Limited Announces First Quarter 2024 Financial Results and Business Update
- VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business Update
- Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antech
More ▼
Key statistics
On Wednesday, VolitionRX Ltd (VNRX:ASQ) closed at 0.645, 17.27% above the 52 week low of 0.55 set on Dec 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.6551 |
---|---|
High | 0.6551 |
Low | 0.621 |
Bid | 0.63 |
Offer | 0.71 |
Previous close | 0.63 |
Average volume | 115.25k |
---|---|
Shares outstanding | 82.93m |
Free float | 63.31m |
P/E (TTM) | -- |
Market cap | 53.49m USD |
EPS (TTM) | -0.4603 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 22:00 BST.
More ▼